Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Gerda, Silling"'
Autor:
Benjamin Rolles, Robert Meyer, Matthias Begemann, Miriam Elbracht, Edgar Jost, Matthias Stelljes, Ingo Kurth, Tim H. Brümmendorf, Gerda Silling
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-3 (2023)
Externí odkaz:
https://doaj.org/article/0b4a84eaa8a04567b904bd77dcf1c1f7
Autor:
Amadeus T Heinz, Friso G.J. Calkoen, Alexander Derbich, Lea Miltner, Christian Seitz, Michaela Doering, Christiane Braun, Daniel Atar, Michael Schumm, Florian Heubach, Anne-Marie Arendt, Ansgar Schulz, Friedhelm R Schuster, Roland Meisel, Brigitte Strahm, Juergen Finke, Beatrice Heineking, Susanne Stetter, Gerda Silling, Daniel Stachel, Bernd Gruhn, Klaus-Michael Debatin, Juergen Foell, Johannes H Schulte, Wilhelm Woessmann, Christine Mauz-Körholz, Johanna Tischer, Tobias Feuchtinger, Rupert Handgretinger, Peter Lang
Publikováno v:
Haematologica, Vol 108, Iss 8 (2023)
Therapy-resistant viral reactivations contribute significantly to mortality after hematopoietic stem cell transplantation. Adoptive cellular therapy with virus-specific T cells (VST) has shown efficacy in various single-center trials. However, the sc
Externí odkaz:
https://doaj.org/article/6ada467cb16540358957b223184585b6
Autor:
Tim H. Brümmendorf, Stefan Wilop, Gerda Silling, Martina Wessiepe, Judith Gecht, Hatice Soysal, Martina Crysandt, Edgar Jost, Eva Jennes, Tobias A. W. Holderried, Udo Holtick, Matthias Mrotzek, Fabian Beier, Susanne Rehnelt, Uta Kunter
Publikováno v:
European Journal of Haematology. 107:324-332
OBJECTIVE ABO mismatch between donor and recipient occurs in 40% of allogeneic hematopoietic stem cell transplantations (HCT). Different strategies have been described to reduce isohemagglutinins (IHA) before HCT. We describe the effect of selective
Autor:
Jorg-Janne Vehreschild, B. Grüner, J. Kessel, D. Seidel, S.M. Heimann, Gerda Silling, Maria J G T Vehreschild, Oliver A. Cornely, Werner J. Heinz
Publikováno v:
Journal of Hospital Infection. 101:339-346
Invasive mucormycosis (IM) is a rare invasive fungal infection with a high mortality rate. However, data concerning the clinical and economic burden of IM are scarce.To evaluate the direct treatment costs and additional expenditures of patients with
Autor:
Matthias Stelljes, Dietrich W. Beelen, Jan Braess, Maria C. Sauerland, Achim Heinecke, Björna Berning, Hans J. Kolb, Ernst Holler, Rainer Schwerdtfeger, Renate Arnold, Karsten Spiekermann, Carsten Müller-Tidow, Hubert L. Serve, Gerda Silling, Wolfgang Hiddemann, Wolfgang E. Berdel, Thomas Büchner, Joachim Kienast
Publikováno v:
Haematologica, Vol 96, Iss 7 (2011)
Background Allogeneic hematopoietic cell transplantation is considered the preferred post-remission therapy in patients with acute myeloid leukemia cytogenetically defined as being at high risk. To substantiate evidence for allogeneic hematopoietic c
Externí odkaz:
https://doaj.org/article/d52df787c6394936a3afffd6369f9fb7
Autor:
Martin Schmidt-Hieber, Julie Schwender, Werner J. Heinz, Tatjana Zabelina, Jörn S. Kühl, Sabine Mousset, Silke Schüttrumpf, Christian Junghanss, Gerda Silling, Nadezda Basara, Stefan Neuburger, Eckhard Thiel, Igor W. Blau
Publikováno v:
Haematologica, Vol 96, Iss 1 (2011)
Background Limited data are available on characteristics of viral encephalitis in patients after allogeneic stem cell transplantation.Design and Methods We analyzed 2,628 patients after allogeneic stem cell transplantation to identify risk factors an
Externí odkaz:
https://doaj.org/article/cb8b55f5ba1747839023bb6831a65344
Autor:
E. Fiegle, Edgar Jost, Matthias Begemann, Fabian Beier, Tim H. Brümmendorf, Anne-Sophie Bouillon, Gerda Silling, Miriam Elbracht, Martina Crysandt
Publikováno v:
Leukemia Research. 108:106609
Autor:
M. von Lilienfeld-Toal, Christina Rieger, Karin Mayer, Maria J G T Vehreschild, Andrew J. Ullmann, Sibylle C. Mellinghoff, H.-H. Wolf, Werner J. Heinz, Michael Sandherr, Georg Maschmeyer, Dieter Buchheidt, Gerlinde Egerer, N. Lehners, M. Hentrich, Blasius Liss, Oliver A. Cornely, Gerda Silling
Infectious complications are a significant cause of morbidity and mortality in patients with malignancies specifically when receiving anticancer treatments. Prevention of infection through vaccines is an important aspect of clinical care of cancer pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbbc29bc0c2c6118b0f38850c4fee244
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/22619
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/22619
Autor:
Hellmut Ottinger, Matthias Stelljes, Gerda Silling, Christian Reicherts, Markus Ditschkowski, Christoph Groth, Wolfgang E. Berdel, Jan-Henrik Mikesch, Carsten Mueller-Tidow, Christoph Schliemann, Georg Lenz, Joern C. Albring, Rudolf Trenschel, Dietrich W. Beelen, Lambros Kordelas, Eva Schmidt, Nina K. Steckel
Considering the unsatisfactory results of salvage therapies for patients with relapsed/refractory acute myeloid leukaemia (R/R-AML), their value before allogeneic haematopoietic stem cell transplantation (HSCT) remains questionable. However, direct a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::720821eb7fcf79588e341e017868be1d
https://www.ncbi.nlm.nih.gov/pubmed/29468631
https://www.ncbi.nlm.nih.gov/pubmed/29468631
Autor:
Carsten Müller-Tidow, Gerda Silling, Rolf M. Mesters, Christoph Groth, Torsten Kessler, Jörn C. Albring, Dennis Görlich, M Stelljes, Wolfgang E. Berdel, R Besoke, Th. Büchner, Tim Sauer, Felix Rosenow, Utz Krug, Georg Evers
Publikováno v:
Bone Marrow Transplantation. 50:485-492
Non-relapse mortality after Allo-SCT has significantly decreased over the last years. Nevertheless, relapse remains a major cause for post SCT mortality in patients with AML and high-risk myelodysplastic syndrome (MDS). In this retrospective single-c